Difference between revisions of "Graft versus host disease"

From HemOnc.org - A Hematology Oncology Wiki
Jump to navigation Jump to search
Line 23: Line 23:
 
===Glucksberg grade===
 
===Glucksberg grade===
  
{| border="1"  
+
{| border="1" style="text-align:center;"
!Overall grade
+
!align="left" | Overall grade
 
!I
 
!I
 
!II
 
!II
Line 30: Line 30:
 
!IV
 
!IV
 
|-
 
|-
|Skin
+
|align="left" | Skin
 
|1-2
 
|1-2
 
|1-3
 
|1-3
Line 36: Line 36:
 
|2-4
 
|2-4
 
|-
 
|-
|GI
+
|align="left" | GI
 
|0
 
|0
 
|1
 
|1
Line 42: Line 42:
 
|2-4
 
|2-4
 
|-
 
|-
|Liver
+
|align="left" | Liver
 
|0
 
|0
 
|1
 
|1
Line 60: Line 60:
 
The severity is the highest level which the patient reaches based on separate skin, liver, and GI staging.
 
The severity is the highest level which the patient reaches based on separate skin, liver, and GI staging.
  
{| border="1"  
+
{| border="1" style="text-align:center;"
!Overall grade
+
!align="left" | Overall grade
 
!A
 
!A
 
!B
 
!B
Line 67: Line 67:
 
!D
 
!D
 
|-
 
|-
|Skin
+
|align="left" | Skin
 
|1
 
|1
 
|2
 
|2
Line 73: Line 73:
 
|4
 
|4
 
|-
 
|-
|GI
+
|align="left" | GI
 
|0
 
|0
 
|1-2
 
|1-2
Line 79: Line 79:
 
|4
 
|4
 
|-
 
|-
|Liver
+
|align="left" | Liver
 
|0
 
|0
 
|1-2
 
|1-2

Revision as of 07:40, 10 December 2011

Glucksberg acute graft versus host (GVHD) scores

Skin

  • Stage 0: No rash
  • Stage 1: Maculopapular rash <25% of body surface area
  • Stage 2: Maculopapular rash on 25-50% of body surface area
  • Stage 3: Generalized erythroderma
  • Stage 4: Generalized erythroderma with bullous formation and desquamation

Liver

  • Stage 0: Bilirubin <2 mg/dL
  • Stage 1: Bilirubin 2-3 mg/dL
  • Stage 2: Bilirubin 3.01-6 mg/dL
  • Stage 3: Bilirubin 6.01-15.0 mg/dL
  • Stage 4: Bilirubin >15 mg/dL

GI

  • Stage 0: No diarrhea, or diarrhea <500 mL/day
  • Stage 1: Diarrhea 500-999 mL/day
  • Stage 2: Diarrhea 1000-1499 mL/day
  • Stage 3: Diarrhea >1500 mL/day
  • Stage 4: Severe abdominal pain, with or without ileus

Glucksberg grade

Overall grade I II III IV
Skin 1-2 1-3 2-3 2-4
GI 0 1 2-3 2-4
Liver 0 1 2-4 2-4
Karnofsky performance scale 90-100% 70-80% 50-60% 30-40%

IBMTR severity index

The severity is the highest level which the patient reaches based on separate skin, liver, and GI staging.

Overall grade A B C D
Skin 1 2 3 4
GI 0 1-2 3 4
Liver 0 1-2 3 4

Chronic GVHD

Localized

  • Localized skin and/or liver dysfunction due to chronic GVHD

Extensive

  • Generalized skin involvement or localized skin and/or liver dysfunction due to chronic GVHD plus at least one of the following:
    • Liver biopsy showing cirrhosis, chronic aggressive hepatitis, bridging necrosis
    • Eye involvement, defined as Schirmer's test with <5 mm wetting
    • Involvement of oral mucosa on lip biopsy or minor salivary glands
    • Other organ involvement
  • Overall severity categories: mild/moderate/severe

References

  1. Thomas E, Storb R, Clift RA, Fefer A, Johnson FL, Neiman PE, Lerner KG, Glucksberg H, Buckner CD. Bone-marrow transplantation (first of two parts). N Engl J Med. 1975 Apr 17;292(16):832-43 link to original article PubMed
  2. Thomas ED, Storb R, Clift RA, Fefer A, Johnson L, Neiman PE, Lerner KG, Glucksberg H, Buckner CD. Bone-marrow transplantation (second of two parts). N Engl J Med. 1975 Apr 24;292(17):895-902 link to original article (contains staging scale) PubMed
  3. Rowlings PA, Przepiorka D, Klein JP, Gale RP, Passweg JR, Henslee-Downey PJ, Cahn JY, Calderwood S, Gratwohl A, Socié G, Abecasis MM, Sobocinski KA, Zhang MJ, Horowitz MM. IBMTR Severity Index for grading acute graft-versus-host disease: retrospective comparison with Glucksberg grade. Br J Haematol. 1997 Jun;97(4):855-64. link to original article PubMed